Nasdaq Pdsb News Today

PDS Biotechnology Co. (NASDAQ:PDSB – Get Free Report) shares were down 8.8% on Friday . The stock traded as low as $2.59 and last traded at $2.65. Approximately 881,240 shares were traded during trading, a decline of 0% from the average daily volume of 884,327 shares. The stock had previously closed at $2.90. Wall Street […]

PDS Biotechnology (NASDAQ:PDSB – Free Report) had its price objective cut by Oppenheimer from $23.00 to $20.00 in a research report released on Wednesday morning, Benzinga reports. They currently have an outperform rating on the stock. A number of other equities analysts also recently issued reports on PDSB. B. Riley reaffirmed a buy rating on […]

StockNews.com started coverage on shares of PDS Biotechnology (NASDAQ:PDSB – Free Report) in a report issued on Thursday morning. The brokerage issued a sell rating on the stock. Separately, HC Wainwright reissued a buy rating and set a $21.00 target price on shares of PDS Biotechnology in a research note on Wednesday, September 27th. View […]

PDS0202 (Infectimune® + COBRA influenza antigens) vaccination also prevented illness/weight loss Vaccine protected against replication of the virus in the...

HC Wainwright restated their buy rating on shares of PDS Biotechnology (NASDAQ:PDSB – Free Report) in a research note released on Monday morning, Benzinga reports. The brokerage currently has a $21.00 target price on the stock. HC Wainwright also issued estimates for PDS Biotechnology’s Q3 2023 earnings at ($0.45) EPS, Q4 2023 earnings at ($0.48) […]

PDS Biotechnology (NASDAQ:PDSB – Get Free Report) will be issuing its quarterly earnings data before the market opens on Monday, August 14th. Analysts expect the company to announce earnings of ($0.37) per share for the quarter. PDS Biotechnology (NASDAQ:PDSB – Get Free Report) last posted its earnings results on Monday, May 15th. The company reported […]

PDS Biotechnology Co. (NASDAQ:PDSB – Get Rating) saw a large growth in short interest in the month of May. As of May 31st, there was short interest totalling 2,680,000 shares, a growth of 27.0% from the May 15th total of 2,110,000 shares. Based on an average trading volume of 693,800 shares, the days-to-cover ratio is […]

FLORHAM PARK, N.J., June 05, 2023 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing a...

PDS Biotechnology (NASDAQ:PDSB – Get Rating) and Silverback Therapeutics (NASDAQ:SBTX – Get Rating) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their valuation, profitability, institutional ownership, risk, earnings, dividends and analyst recommendations. Profitability This table compares PDS Biotechnology and Silverback Therapeutics’ […]

PDS Biotechnology Co. (NASDAQ:PDSB – Get Rating)’s stock price was down 3.9% on Monday . The stock traded as low as $6.13 and last traded at $6.33. Approximately 281,786 shares traded hands during mid-day trading, a decline of 42% from the average daily volume of 482,226 shares. The stock had previously closed at $6.59. Wall […]